The report examines six areas that contribute to unnecessary costs. The areas are medication nonadherence, delayed evidence-based treatment practice, misuse of antibiotics, medication errors, suboptimal use of generics and mismanaged polypharmacy in older adults.
Key findings of the report include:
• Medication nonadherence drives the largest avoidable cost, an estimated $105 billion annually.
• Delays in applying evidence-based treatment to patients lead to $40 billion in annual avoidable costs.
• Some signs of improvement are evident in the responsible use of antibiotics.
• Many efforts are underway to address the underlying causes of avoidable spending and to improve medication use.
More Articles on Pain Management:
Wake Forest Baptist Health-Lexington Medical Center Shifts Pain Management, Anesthesia Services
ASIPP Names Dr. Joshua Hirsch Editor-In-Chief of Pain Physician
ASIPP Announces 23 New Board of Directors Members
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
